Xiao-yu Jing

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Management of persistent soft tissue residuals exhibiting an imaging paradox (^123I-MIBG-negative/^68Ga-DOTA-NOC-positive) in high-risk neuroblastoma following immunotherapy: a case report.

Management of persistent soft tissue residuals exhibiting an imaging paradox (^123I-MIBG-negative/^68Ga-DOTA-NOC-positive) in high-risk neuroblastoma following immunotherapy: a case report.

Journal: Frontiers in immunology

Published: April 28, 2026

Therapy-related acute myeloid leukemia following successful treatment of high-risk neuroblastoma in a pediatric patient: a case report and insights into late complications.

Therapy-related acute myeloid leukemia following successful treatment of high-risk neuroblastoma in a pediatric patient: a case report and insights into late complications.

Journal: Frontiers in oncology

Published: January 06, 2026

Efficacy, safety, and relapse outcomes of MAPK inhibitors in pediatric Langerhans cell histiocytosis: A real-world study.

Efficacy, safety, and relapse outcomes of MAPK inhibitors in pediatric Langerhans cell histiocytosis: A real-world study.

Journal: International journal of cancer

Published: July 22, 2025

Dissecting neuroblastoma heterogeneity through single-cell multi-omics: insights into development, immunity, and therapeutic resistance.

Dissecting neuroblastoma heterogeneity through single-cell multi-omics: insights into development, immunity, and therapeutic resistance.

Journal: Oncogene

Published: June 24, 2025

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review.

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review.

Journal: Frontiers in immunology

Published: May 08, 2025

Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.

Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.

Journal: Molecular cancer

Published: November 01, 2024

Effective Treatment of Anlotinib Combined With Chemotherapy in Children With Desmoplastic Small Round Cell Tumor: A Case Series in a Single-center and Literature Review.

Effective Treatment of Anlotinib Combined With Chemotherapy in Children With Desmoplastic Small Round Cell Tumor: A Case Series in a Single-center and Literature Review.

Journal: Journal of pediatric hematology/oncology

Published: September 25, 2023

Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.

Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.

Journal: International journal of clinical and experimental pathology

Published: September 29, 2014

Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.

Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 09, 2013

Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.

Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: December 19, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026